Purpose
to better treat environmental enteropathy in infants in developing countries by engineering bacteriophage to selectively target the causative gut pathogens such as Shigella and Salmonella using CRISPR-Cas9 nucleases.
Grantee
Division
Global Health
Date
OCTOBER 2015
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
25
Grantee location
Edinburgh, Edinburgh, City of, United Kingdom
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.